Graduate faculty member Ke Xu has invented a new technology to image single molecules with unprecedented spectral and spatial resolution, thus leading to the first “true-color” super-resolution microscope.
Researchers in bioengineering professor Chris Anderson’s lab have used synthetic biology to develop an easy way to lock down bacteria, to contain its accidental spread. The work, led by recent BioE Ph.D. Gabriel Lopez, shows promise as a potential method of containing advances created through synthetic biology and genetic engineering.
Austin Roorda, UC Berkeley professor of optometry and vision science and member of the graduate program, is lead investigator on an ambitious new project to map the interaction of retinal cells in an effort to better understand how visual data is processed before it is sent to the brain. The research is funded by the National Eye Institute’s Audacious Goals Initiative.
Professor Michelle Chang, member of the graduate program in bioengineering and UC Berkeley professor of chemistry, is one of the lead researchers developing a hybrid system of semiconducting nanowires and bacteria that mimics the natural photosynthetic process.
A team of researchers, including UC Berkeley professor Michel Maharbiz and UCSF professor Shuvo Roy, have developed new sensor-packed “smart bandages” that actually detect damage to the skin before it becomes visible, allowing caregivers to prevent the formation of infection-prone bedsores.
UC Berkeley professor Michel Maharbiz is know for his work hard-wiring beetles for radio-controlled flight. That work is now allowing researchers to learn new things about the muscles insects use to steer.
A profile from the Bakar Fellows Program explains how UC Berkeley professor Shawn Shadden uses advanced computer modeling to help doctors find the best treatment for patients undergoing a stroke.
For the second year in a row, UC San Francisco’s four schools topped the nation in federal biomedical research funding in their fields in 2014, with the graduate-level university as a whole receiving the most of any public recipient and second most overall in funds from the National Institutes of Health (NIH), according to annual NIH figures.